Fig. 3From: Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension studyFreedom from nausea, photophobia, and phonophobia at 2 h after treatment with DFN-11Back to article page